The German defense electronics specialist Hensoldt finds itself in an enviable yet challenging position: its order book is overflowing, but translating those contracts into revenue is proving difficult. Management is now implementing a decisive strategic shift to bridge this gap, a move that has prompted two prominent analyst firms to upgrade their ratings on the company’s stock.
A Widening Chasm Between Orders and Revenue
Hensoldt’s fundamental issue is one of execution. In its last fiscal year, the value of new orders surged by 62% to reach €4.71 billion. This influx has ballooned the total order backlog to a massive €8.83 billion, a sum exceeding three times the company’s annual revenue. However, actual sales growth tells a different story, rising a more modest 9.6% to €2.45 billion. The data reveals a production apparatus operating at its limits, unable to keep pace with incoming demand.
A Two-Pronged Strategy for Capacity Expansion
To alleviate this critical bottleneck, the executive board has swiftly activated two key initiatives. First, the company is acquiring its long-standing Dutch partner, Nedinsco. This optics specialist contributes approximately 140 employees and, more importantly, immediate manufacturing capacity. Second, Hensoldt is accelerating a physical expansion of its site in Aalen.
These steps are part of a broader, aggressive investment program. Between 2025 and 2027, roughly one billion euros will be directed toward capacity expansion. In parallel, the company plans to create 1,600 new jobs in the coming year alone.
Market Analysts Spot a Valuation Opportunity
The financial markets have responded favorably to this clear action plan. Analysts at both Jefferies and Warburg Research recently revised their stance on Hensoldt shares, upgrading from “Hold” to “Buy.” A core part of their thesis is the stock’s compressed valuation. Hensoldt’s historical premium compared to European peers has shrunk from nearly 50% to around 10%. With shares closing at €78.65, the price sits roughly 31% below its 52-week high.
Warburg Research identifies this as an attractive entry point, subsequently raising its price target to €91. Notably, CEO Oliver Dörre appears to share this confidence, having recently purchased 1,000 shares for his private portfolio.
In the near term, capacity constraints are expected to continue weighing on operational momentum. Management’s sales guidance for the current year of approximately €2.75 billion remains slightly below current market expectations. Investors will gain clearer insight into the progress of working down the record backlog with the release of the audited financial statements on March 26, followed by first-quarter figures on May 6.
